The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

被引:1032
|
作者
Kansanen, Emilia [1 ]
Kuosmanen, Suvi M. [1 ]
Leinonen, Hanna [1 ]
Levonen, Anna-Liisa [1 ]
机构
[1] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland
来源
REDOX BIOLOGY | 2013年 / 1卷 / 01期
基金
芬兰科学院;
关键词
Nrf2; Keap1; Cancer; Antioxidant response element; Gene therapy; NRF2; EFFICACY;
D O I
10.1016/j.redox.2012.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Keap1-Nrf2 pathway is the major regulator of cytoprotective responses to oxidative and electrophilic stress. Although cell signaling pathways triggered by the transcription factor Nrf2 prevent cancer initiation and progression in normal and premalignant tissues, in fully malignant cells Nrf2 activity provides growth advantage by increasing cancer chemoresistance and enhancing tumor cell growth. In this graphical review, we provide an overview of the Keap1-Nrf2 pathway and its dysregulation in cancer cells. We also briefly summarize the consequences of constitutive Nrf2 activation in cancer cells and how this can be exploited in cancer gene therapy. (C) 2013 The Authors. Published by Elsevier B.V.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 50 条
  • [31] UHRF1 regulation of the Keap1-Nrf2 pathway in pancreatic cancer contributes to oncogenesis
    Abu-Alainin, Wafa
    Gana, Thompson
    Liloglou, Triantafillos
    Olayanju, Adedamola
    Barrera, Lawrence N.
    Ferguson, Robert
    Campbell, Fiona
    Andrews, Timothy
    Goldring, Christopher
    Kitteringham, Neil
    Park, Brian K.
    Nedjadi, Taoufik
    Schmid, Michael C.
    Slupsky, Joseph R.
    Greenhalf, William
    Neoptolemos, John P.
    Costello, Eithne
    JOURNAL OF PATHOLOGY, 2016, 238 (03): : 423 - 433
  • [32] Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control
    Ghosh, Ayan K.
    Su, Yu-Pin
    Forman, Michael
    Keyes, Robert F.
    Smith, Brian C.
    Hu, Xin
    Ferrer, Marc
    Arav-Boger, Ravit
    JOURNAL OF VIROLOGY, 2023, 97 (04)
  • [33] Proteomic and Functional Analyses of Keap1-Nrf2 Pathway in Skeletal Muscle
    Gao, Lie
    Kumar, Vikas
    Hackfort, Bryan
    Rudebush, Tara L.
    Yu, Li
    Schultz, Harold D.
    Zucker, Irving H.
    FASEB JOURNAL, 2019, 33
  • [34] Keap1-Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
    Kensler, Thomas W.
    Egner, Patricia A.
    Agyeman, Abena S.
    Visvanathan, Kala
    Groopman, John D.
    Chen, Jian-Guo
    Chen, Tao-Yang
    Fahey, Jed W.
    Talalay, Paul
    NATURAL PRODUCTS IN CANCER PREVENTION AND THERAPY, 2013, 329 : 163 - 177
  • [35] The KEAP1-NRF2 System as a Molecular Target of Cancer Treatment
    Taguchi, Keiko
    Yamamoto, Masayuki
    CANCERS, 2021, 13 (01) : 1 - 21
  • [36] Somatic Mutations in KEAP1-NRF2 Complex in Breast Cancer
    Almeida, Micaela
    Ferreira, Catarina L.
    Tome, Rosa Maria
    Fonseca-Moutinho, Jose
    Polonia, Antonio
    Ramalhinho, Ana Cristina
    Breitenfeld, Luiza
    CANCERS, 2024, 16 (13)
  • [37] Keap1-Nrf2 signaling: a target for cancer prevention by sulforaphane
    Kensler, Thomas W.
    ANTI-CANCER DRUGS, 2015, 26 : E3 - E4
  • [38] Keap1-Nrf2 Pathway Regulates ALDH and Contributes to Radioresistance in Breast Cancer Stem Cells
    Kamble, Dinisha
    Mahajan, Megharani
    Dhat, Rohini
    Sitasawad, Sandhya
    CELLS, 2021, 10 (01) : 1 - 21
  • [39] Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
    Jiang-Jiang Qin
    Xiang-Dong Cheng
    Jia Zhang
    Wei-Dong Zhang
    Cell Communication and Signaling, 17
  • [40] Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
    Qin, Jiang-Jiang
    Cheng, Xiang-Dong
    Zhang, Jia
    Zhang, Wei-Dong
    CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)